BRIDGEBIO PHARMA INC.
25.88
07-November-24 14:59:59
15 minutes delayed
Stocks
+0.27
+1.05%
Today's range
25.34 - 26.15
ISIN
N/A
Source
NASDAQ
-
05 Nov 2024 06:30:00 By Nasdaq GlobeNewswire
-
24 Oct 2024 06:30:00 By Nasdaq GlobeNewswire
-
30 Sep 2024 06:30:00 By Nasdaq GlobeNewswire
-
17 Sep 2024 06:30:00 By Nasdaq GlobeNewswire
-
10 Sep 2024 15:45:00 By Nasdaq GlobeNewswire
-
10 Sep 2024 15:45:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
06 Sep 2024 06:30:00 By Nasdaq GlobeNewswire
-
30 Aug 2024 09:50:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma to Participate in September Investor Events
28 Aug 2024 06:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Launches MyAchonJourney, a New Resource for Families Navigating Achondroplasia
19 Aug 2024 06:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08 Aug 2024 06:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Second Quarter 2024 Financial Results and Business Update
01 Aug 2024 06:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Announces Appointment of Thomas Trimarchi, Ph.D., as President and Chief Operating Officer
23 Jul 2024 06:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
05 Jul 2024 15:31:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
10 Jun 2024 06:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >